Ignite Creation Date:
2024-05-06 @ 7:09 PM
Last Modification Date:
2024-10-26 @ 3:01 PM
Study NCT ID:
NCT05914779
Status:
RECRUITING
Last Update Posted:
2023-11-18
First Post:
2023-05-30
Brief Title:
Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest OHCA
Sponsor:
Hamad Medical Corporation
Organization:
Hamad Medical Corporation
Study Overview
Official Title:
Impact of Early Antibiotics on Non-Traumatic Out of Hospital Cardiac Arrest OHCA
Status:
RECRUITING
Status Verified Date:
2023-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Specific Aim The specific aim is to conduct a randomized prospective clinical trial to determine whether no antibiotics in OHCA patients in the ED with very low likelihood of infection is non-inferior to early antibiotic treatment Hypothesis a 28-day all-cause mortality will be non-inferior in OHCA patients with very low likelihood of infection who do not receive antibiotic therapy compared with those who receive early antibiotic therapy Hypothesis b There will be no difference in subsequent incidence of proven infections in the no antibiotics vs early antibiotics groups Hypothesis c There will be no difference in the length of ICU stay and overall hospital stay in the early antibiotics vs no antibiotics groups
Detailed Description:
As above
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None